WP
CLYM

Woodline Partners’s Climb Bio CLYM Stock Holding History

Woodline Partners’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.6M Buy
+1,582,291
New +$16.3M 0.06% 359
2024
Q3 		– Sell
-22,192
Closed -$158K – 726
2024
Q2 		$158K Buy
+22,192
New +$148K ﹤0.01% 536
2022
Q4 		– Sell
-226,604
Closed -$732K – 858
2022
Q3 		$732K Sell
226,604
-146,764
-39% -$468K 0.01% 559
2022
Q2 		$1.13M Hold
373,368
– – 0.02% 503
2022
Q1 		$3.13M Hold
373,368
– – 0.05% 305
2021
Q4 		$3.9M Sell
373,368
-13,856
-4% -$207K 0.06% 316
2021
Q3 		$6.96M Buy
+387,224
New +$8M 0.11% 214

Other funds holding CLYM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Woodline Partners's CLYM Position: Q2 2026 in Review

Woodline Partners opened a new position in Climb Bio (CLYM) in Q2 2026: 1,582,291 shares worth $20.6M. The stake represents 0.06% of the portfolio and ranks #359 among its holdings. This is a return to the name: Woodline Partners previously reported a position in CLYM as recently as Q2 2024.

Woodline Partners first reported a position in CLYM in Q3 2021 and has held it in 7 quarters since. 109 funds tracked by Wall St. Rank hold CLYM as of Q2 2026.

  • Woodline Partners held 1,582,291 shares of Climb Bio worth $20.6M as of Q2 2026.
  • Climb Bio was a new Woodline Partners position in Q2 2026.
  • Climb Bio made up 0.06% of Woodline Partners's portfolio in Q2 2026, its #359 holding.
  • Woodline Partners first reported a position in Climb Bio in Q3 2021 and has held it in 7 quarters since.
  • 109 funds tracked by Wall St. Rank held Climb Bio as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.